Patel Chem Specialities IPO is a book-built issue IPO, aiming to raise ₹58.80 crore. It comprises a fresh issue of 70.00 lakh equity shares. The bidding window was open from July 25, 2025, to July 29, 2025, with the IPO allotment to be finalised on July 30, 2025. Patel Chem Specialities is scheduled to list on BSE SME on August 1, 2025.
The IPO was priced at ₹82-₹84 per share with a lot size of 3,200 shares. The public issue received bids for 77,95,85,600 shares against 46,59,200 shares available, resulting in an overall subscription of 167.32 times. NIIs led the response, subscribing 236.62 times their quota, followed by retail investors at 173.03 times.
Patel Chem Specialities' ₹58.80 crore IPO, priced at ₹82-₹84 per share, was subscribed 167.32 times overall. The IPO is a fresh issue of 70.00 lakh equity shares. Bidding took place from July 25 to July 29, 2025, with the Patel Chem Specialities IPO allotment status on July 30, 2025. Retail investors subscribed 173.03 and NIIs 236.62 times. Listing is expected on August 1, 2025.
The table below breaks down the Patel Chem Specialities share allocation for different categories, highlighting the number of shares and their percentage of the total issue. However, the key focus remains on the quotas allocated to retail investors and HNIs, as they are the most relevant for individual investors.
| Investor Category | Shares Offered |
| Market Maker Shares Offered | 3,53,600 (5.05%) |
| QIB Shares Offered | 33,16,800 (47.38%) |
| − Anchor Investor Shares Offered | 19,87,200 (28.39%) |
| − QIB (Ex. Anchor) Shares Offered | 13,29,600 (18.99%) |
| NII (HNI) Shares Offered | 9,98,400 (14.26%) |
| − bNII > ₹10L | 10,19,200 (14.56%) |
| − sNII < ₹10L | 3,32,800 (4.75%) |
| Retail Shares Offered | 23,31,200 (33.30%) |
| Total Shares Offered | 70,00,000 (100.00%) |
Data Source: BSE
| Category | Subscription (times) |
| Qualified Institutional Buyers | 105.27 |
| Non-Institutional Investors | 236.62 |
| Retail Individual Investors | 173.03 |
| Total shares | 167.32 |
Note: The subscription details are as of July 29, 2025
Patel Chem Specialities Limited was initially incorporated as Patel Chem Specialities Private Limited on June 25, 2008, under the Companies Act, 1956. Following a special resolution passed on July 4, 2024, the company was converted into a public limited company and renamed Patel Chem Specialities Limited. A fresh certificate of incorporation reflecting this change was issued on August 29, 2024, signifying the company’s readiness to broaden its reach and operations.
The company is engaged in the manufacturing of cellulose-based excipients, which are vital ingredients used across the pharmaceutical, nutraceutical, food and beverage, cosmetic, and industrial sectors. These excipients act as binders, disintegrants, thickeners, stabilisers, and gelling agents. They are essential in the formulation of tablets, food additives, and various personal care products, contributing to both product performance and safety.
Patel Chem Specialities operates from two manufacturing facilities located in Vatva and Talod, Gujarat. The company adheres to stringent quality standards and holds international certifications such as US-DMF, GMP, and ISO 9001:2015. Its product portfolio includes Sodium Monochloro Acetate (SMCA), Sodium Starch Glycolate (SSG), Croscarmellose Sodium (CCS), Calcium Carboxymethyl Cellulose (Calcium CMC), Sodium Carboxymethyl Cellulose (Sodium CMC), and Microcrystalline Cellulose (MCC), catering to a wide array of industrial applications.
With a strong domestic presence in states like Gujarat, Maharashtra, and West Bengal, the company has also established a global footprint, exporting to over 15 countries including the United States, Germany, Japan, South Korea, and the United Kingdom. Patel Chem’s growth strategy focuses on expanding its manufacturing capacity, improving product quality, and strengthening its market position globally. Backed by its technical know-how and focus on innovation, the company aims to solidify its standing in the specialty chemicals industry and meet the growing global demand for pharmaceutical-grade excipients.
Know more about IPO allotment status and check your application details online for the latest updates on share allocation.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jul 29, 2025, 7:24 PM IST
Akshay Shivalkar
Akshay Shivalkar is a financial content specialist who strategises and creates SEO-optimised content on the stock market, mutual funds, and other investment products. With experience in fintech and mutual funds, he simplifies complex financial concepts to help investors make informed decisions through his writing.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
